Galectin Therapeutics
GALT
#8646
Rank
NZ$0.22 B
Marketcap
$3.63
Share price
-1.89%
Change (1 day)
40.73%
Change (1 year)

Galectin Therapeutics (GALT) - Cash on Hand

Cash on Hand as of September 2024 : NZ$47.17 Million

According to Galectin Therapeutics's latest financial reports the company has NZ$47.17 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Galectin Therapeutics - Cash on Hand chart (from 2001 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31NZ$29.28 M-49.55%
2021-12-31NZ$58.04 M54.31%
2020-12-31NZ$37.61 M-46.64%
2019-12-31NZ$70.49 M472.99%
2018-12-31NZ$12.3 M186.21%
2017-12-31NZ$4.29 M-80.62%
2016-12-31NZ$22.17 M-41.27%
2015-12-31NZ$37.76 M1.58%
2014-12-31NZ$37.17 M191.26%
2013-12-31NZ$12.76 M12.13%
2012-12-31NZ$11.38 M38.88%
2011-12-31NZ$8.19 M7.34%
2010-12-31NZ$7.63 M2109.61%
2009-12-31NZ$0.34 M-36.94%
2008-12-31NZ$0.54 M-68.18%
2007-12-31NZ$1.72 M-78.99%
2006-12-31NZ$8.19 M25.41%
2005-12-31NZ$6.53 M-56.44%
2004-12-31NZ$15 M28.17%
2003-12-31NZ$11.7 M218.81%
2002-12-31NZ$3.67 M2.23%
2001-12-31NZ$3.59 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$1.70 B 3,508.40%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.43 B 829.74%๐Ÿ‡บ๐Ÿ‡ธ USA